Zitat des Tages von Aaron Ciechanover:
The evolvement of proteolysis as a centrally important regulatory mechanism is a remarkable example for the development of a novel biological concept and the accompanying battles to change paradigms.
Reticulocytes are terminally differentiating red blood cells that do not contain lysosome. Therefore, it was postulated that the degradation of hemoglobin in these cells is mediated by a non-lysosomal machinery.
We need to save the education system. We need to remove education from the framework of the political parties that rule in the State of Israel. We need to increase the allocation of long-term national resources to education and never touch them - no matter what.
Towards the end of the military service, I had to make what I assume has been the most important decision in my career: to start a residency in clinical medicine, in surgery, which was my favorite choice, or to enroll into graduate school and start a career in scientific research. It was clear to me that I was heading for graduate school.
My father left me with his love of Jewish studies and cultural life. To this very day, along with several physicians and scientist colleagues, I take regular periodical lessons taught by a Rabbinical scholar on how the Jewish law views moral and ethical problems related to modern medicine and science.
I grew up in Haifa and enjoyed the wonderful beaches and Mount Carmel that rolls into the Mediterranean Sea. From my early days at home, I remember a strong encouragement to study.
My brother Joseph, who is 14 years older than me, was already on his national military compulsory service when I was 4 years old, the age from which I remember myself.
The scale of time for a politician runs between one primary and the next, and in Israel, this means two to three years because elections almost never take place once every four years as stipulated by law. The timetable for a system of research is completely different.
Bringing together the unique expertise of researchers from both NYU and the Technion will hopefully enable us to overcome some of the most difficult challenges in treating cancer patients.
